FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

396601000001106: Betamethasone+salicylic acid 0.05/3% ointment - product

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2004. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    11598401000001110 Betamethasone+salicylic acid 0.05/3% ointment - product en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    12355801000001113 Betamethasone+salicylic acid 0.05/3% ointment - product en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Betamethasone+salicylic acid 0.05/3% ointment - product Is a Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous ointment false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% ointment - product Availability Available only as a proprietary false Additional relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% ointment - product NHS prescribing status NHS prescribable false Additional relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% ointment - product Legal category Prescription Only Medicine false Additional relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% ointment - product CSM recommendation to report adverse reactions Report only serious adverse reactions to the Committee on Safety of Medicines false Additional relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% ointment - product Product name type Generic name false Additional relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% ointment - product Has active ingredient Corticosterone false Inferred relationship Existential restriction modifier
    Betamethasone+salicylic acid 0.05/3% ointment - product Has active ingredient Betamethasone false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Diprosalic ointment Is a False Betamethasone+salicylic acid 0.05/3% ointment - product Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start